Sulfa Resistance in Pneumocystis carinii Pneumonia
Author Information
Author(s): Nahimana Aimable, Rabodonirina Meja, Helweg-Larsen Jannik, Meneau Isabelle, Francioli Patrick, Bille Jacques, Hauser Philippe M.
Primary Institution: Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Hypothesis
Can mutations in the dihydropteroate synthase (DHPS) gene of Pneumocystis carinii be selected by sulfa or sulfone drug pressure in AIDS patients with recurrent pneumonia?
Conclusion
The study suggests that DHPS mutations in Pneumocystis carinii may be selected in patients under the pressure of sulfa or sulfone drugs, potentially leading to drug resistance.
Supporting Evidence
- The study found that DHPS mutations are associated with failure of sulfa or sulfone prophylaxis.
- Patients with recurrent pneumonia showed a change in DHPS genotype between episodes.
- The majority of second episodes caused by reactivation had mutant DHPS strains.
Takeaway
Some sick people can get the same lung infection more than once, and the medicine they take can make the germs stronger and harder to treat.
Methodology
The study analyzed bronchoalveolar lavage specimens from patients with recurrent Pneumocystis carinii pneumonia to investigate DHPS mutations.
Potential Biases
Potential bias in patient selection and treatment regimens may affect the results.
Limitations
The study's findings may not be generalizable due to the small sample size and specific patient demographics.
Participant Demographics
All participants were AIDS patients, mostly men, with a median age of 35 years.
Statistical Information
P-Value
p<0.02
Statistical Significance
p<0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website